Ver registro no DEDALUS
Exportar registro bibliográfico



In vitro metabolism studies of natural products are crucial in the early development of medicines (2017)

  • Authors:
  • USP Schools: FCFRP; FFCLRP
  • DOI: 10.1007/s11101-016-9482-0
  • Keywords: In vitro metabolism; Natural products; Enzymatic kinetics; Metabolites
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11101-016-9482-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    Versões disponíveis em Acesso Aberto do: 10.1007/s11101-016-9482-0 (Fonte: Unpaywall API)

    Título do periódico: Phytochemistry Reviews

    ISSN: 1568-7767,1572-980X

      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Phytochemistry Reviews

    ISSN: 1568-7767

    Citescore - 2017: 3.61

    SJR - 2017: 1.001

    SNIP - 2017: 1.51

  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCFRP2832172pcd 2832172 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MOREIRA, Fernanda L.; MARQUES, Lucas Maciel Mauriz; LOPES, Norberto Peporine; OLIVEIRA, Anderson Rodrigo Moraes de. In vitro metabolism studies of natural products are crucial in the early development of medicines. Phytochemistry Reviews, Dordrecht, 2017. Disponível em: < > DOI: 10.1007/s11101-016-9482-0.
    • APA

      Moreira, F. L., Marques, L. M. M., Lopes, N. P., & Oliveira, A. R. M. de. (2017). In vitro metabolism studies of natural products are crucial in the early development of medicines. Phytochemistry Reviews. doi:10.1007/s11101-016-9482-0
    • NLM

      Moreira FL, Marques LMM, Lopes NP, Oliveira ARM de. In vitro metabolism studies of natural products are crucial in the early development of medicines [Internet]. Phytochemistry Reviews. 2017 ;Available from:
    • Vancouver

      Moreira FL, Marques LMM, Lopes NP, Oliveira ARM de. In vitro metabolism studies of natural products are crucial in the early development of medicines [Internet]. Phytochemistry Reviews. 2017 ;Available from:

    Referências citadas na obra
    Anderson GD, Rosito G, Mohustsy MA, Elmer GW (2003) Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol 43:643–648
    Androutsopoulos VP, Papakyriakou A, Vourloumis D, Spandidos DA (2011) Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. Bioorg Med Chem 19:2842–2849
    Arora S, Taneja I, Challagundla M, Raju KS, Singh SP, Wahajuddin M (2015) In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data. Toxicol Lett 239:1–8
    Arrowsmith J, Miller P (2013) Trial watch: phase II and phase III attrition rates 2011–2012. Nat Rev Drug Discov 12:569
    Asha S, Vidyavathi M (2010) Role of human liver microsomes in in vitro metabolism of drugs—a review. Appl Biochem Biotechnol 160:1699–1722
    Atanasov AG, Waltenberger B, Wenzig EMP, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, Rollinger JM, Schuster D, Breuss JM, Bochkov V, Mihovilovic MD, Kopp B, Bauer R, Dirsch VM, Stuppner H (2015) Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv 33:1582–1614
    Barth T, Habenschus MD, Moreira FL, Ferreira LS, Lopes NP, Oliveira ARM (2015) In vitro metabolism of the lignan (−)-grandisin, an anticancer drug candidate, by human liver microsomes. Drug Test Anal 7:780–786
    Beekmann K, Actis-Goretta L, Bladeren PJ, Dionisi F, Destaillats F, Rietjens IMCM (2012) A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids. Food Funct 3:1008–1018
    Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, Mcleod J, Obach RS, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA (2003) The conduct of in vitro and in vivo drug–drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhrMA) perspective. Drug Metab Dispos 31:815–832
    Blanz J, Délémonté T, Pearson D, Luneau A, Ritzau M, Gertsch W, Ramstein P, Dayer J, Desrayaud S, Braun E, Aichholz R (2015) Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urine. J Chromatogr B 989:1–10
    Bohmdorfer M, Maier-Salamon A, Taferner B, Reznicek G, Thalhammer T, Hering S, Hufner A, Schuhly W, Jager W (2011) In vitro metabolism and disposition of honokiol in rat and human livers. J Pharm Sci 100:3506–3516
    Brantley SJ, Argikar AA, Lin YS, Nagar S, Paine MF (2014) Herb–drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos 42:301–317
    Busti AJ, Hall RG, Margolis DM (2004) Atazanavir for the treatment of human immunodeficiency virus infection. Pharmacotherapy 24:1732–1747
    Buxton ILO, Benet LZ (2011) Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: Brunton L, Chabner B, Knollman B (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 12th edn. McGraw-Hill Professional, New york
    Cao J, Zheng L, Ji L, Lu D, Peng Y, Zheng J (2015) Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin. Chem Biol Interact 226:23–29
    Chen XF, Wu HT, Tan GG, Zhu ZY, Chai YF (2011) Liquid chromatography coupled with time-of-flight and ion trap mass spectrometry for qualitative analysis of herbal medicines. J Pharm Anal 1:235–245
    Chen Z, Zheng S, Li L, Jiang H (2014) Metabolism of flavonoids in human: a comprehensive review. Curr Drug Metab 15:48–61
    Chi M, Peng Y, Zheng J (2016) Characterization of glutathione conjugates derived from reactive metabolites of bakuchiol Meina. Chem Biol Interact 244:178–186
    Chiu NT, Guns EST, Adomat H, Jia W, Deb S (2014) Involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol. Biopharm Drug Dispos 35:104–118
    Choi YH, Chin Y, Kim YG (2011) Herb–drug interactions: focus on metabolic enzymes and transporters. Arch Pharm Res 34:1843–1863
    Colleman MD (2005) Human drug metabolism, 1st edn. Wiley, New Jersey
    Consortium IT (2010) Membrane transporters in drug development. Nature 9:215–236
    Cragg GM, Grothaus PG, Newman DJ (2014) New horizons for old drugs and drug leads. J Nat Prod 77:703–723
    David B, Wolfender J-L, Dias DA (2015) The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev 14:299–315
    Dellinger RW, Garcia AMG, Meyskens JFL (2014) Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences. Drug Metab Pharmacokinet 29:112–119
    DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20–33
    Esch EW, Bahinski A, Huh D (2015) Organs-on-chips at the frontiers of drug discovery. Nat Rev 14:248–260
    Etheridge AS, Black SR, Patel PR, So J, Mathews JM (2007) An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med 73:731–741
    Faeste CK, Ivanova L, Uhlig S (2011) In vitro metabolism of the mycotoxin enniatin B in different species and cytochrome p450 enzyme phenotyping by chemical inhibitors. Drug Metab Dispos 39:1768–1776
    Fandy TE, Abdallah I, Khayat M, Colby DA, Hassan HE (2016) In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine. Cancer chemother Pharmacol 77:259–267
    Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L (2011) Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb–drug interactions. Phytother Res 25:256–263
    Fasinu P, Bouic PJ, Rosenkranz B (2012) Liver-based in vitro technologies for drug biotransformation studies—a review. Curr Drug Metab 13:215–224
    FDA, Food and Drug Administration (2012) Drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations. . Cited 26 Sept 2016
    Feng S, He X (2013) Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity. Curr Drug Metab 14:921–945
    Feng R, Zhou X, Tan XS, Or PM, Hu T, Fu J, Ma JY, Huang M, He CY, Shi JG, Che CT, Yeung JH, Wang Y (2014) In vitro identification of cytochrome P450 isoforms responsible for the metabolism of 1-hydroxyl-2,3,5-trimethoxy-xanthone purified from Halenia elliptica D. Don. Chem Biol Interact 210:12–19
    Fernandes I, Azevedo J, Faria A, Calhau C, de Freitas V, Mateus N (2009) Enzymatic hemisynthesis of metabolites and conjugates of anthocyanins. J Agric Food Chem 57:735–745
    Fofaria NM, Qhattal HSS, Liu X, Srivastava SK (2016) Nanoemulsion formulations for anti-cancer agent piplartine—characterization, toxicological, pharmacokinetics and efficacy studies. Int J Pharmacol 498:12–22
    Friedberg T (2000) Recombinant in vitro tools to predict drug metabolism and safety. Pharm Sci Technol Today 3:99–105
    Genovese S, Epifano F, Curini M, Menger D, Zembruski NC, Weiss J (2011) In vitro effects of natural prenyloxycinnamic acids on human cytochrome P450 isozyme activity and expression. Phytomedicine 18:586–591
    Gomez C, Fabregat A, Pozo OJ, Marcos J, Segura J, Ventura R (2014) Analytical strategies based on mass spectrometric techniques for the study of steroid metabolism. Trends Anal Chem 53:106–116
    Gorrochategui E, Jaumot J, Lacorte S, Tauler R (2016) Data analysis strategies for targeted and untargeted LC–MS metabolomic studies: overview and workflow. Trends Anal Chem 82:425–442
    Hao H, Lai L, Zheng C, Wang Q, Yu G, Zhou X, Wu L, Gong P, Wang G (2010) Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship. Drug Metab Dispos 38:1731–1739
    Harper TW, Brassil PJ (2008) Reaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates. AAPS J 10:200–207
    Harvey AL (2014) Toxins and drug discovery. Toxicon 92:193–200
    He M, Jiang J, Qiu F, Liu S, Peng P, Gao C, Miao P (2013a) Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro. Food Chem Toxicol 57:262–265
    He YJ, Fang ZZ, Ge GB, Jiang P, Jin HZ, Zhang WD, Yang L (2013b) The inhibitory effect of 20(S)-protopanaxatriol (ppt) towards UGT1A1 and UGT2B7. Phytother Res 27:628–632
    Higgins J, Cartwright ME, Templeton AC (2012) Progressing preclinical drug candidates: strategies on preclinical safety studies and the quest for adequate exposure. Drug Discov Today 17:828–836
    Hird SJ, Lau BPY, Schuhmacher R, Krska R (2014) Liquid chromatography-mass spectrometry for the determination of chemical contaminants in food. Trends Anal Chem 59:59–72
    Hua X, Peng X, Tan S, Li C, Wang W, Luo M, Fu Y, Zu Y, Smyth H (2014) In vitro oxidative metabolism of cajaninstilbene acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies. J Agric Food Chem 62:10604–10614
    Huang YP, Cao YF, Fang ZZ, Zhang YY, Hu CM, Sun XY, Yu ZW, Zhu X, Hong M, Yang L, Sun HZ (2013) Glycyrrhetinic acid exhibits strong inhibitory effects towards UDP-glucuronosyltransferase (UGT) 1A3 and 2B7. Phytother Res 27:1358–1361
    Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, Ellis E, van Wenum M, Fuchs SA, de Ligt J, van de Wetering M, Sasaki N, Boers SJ, Kemperman H, de Jonge J, Ijzermans JN, Nieuwenhuis EE, Hoekstra R, Strom S, Vries RR, van der Laan LJ, Cuppen E, Clevers H (2015) Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160:299–312
    Hug C, Krauss M, Nusser L, Hollert H, Brack W (2015) Metabolic transformation as a diagnostic tool for the selection of candidate promutagens in effect-directed analysis. Environ Pollut 196:114–124
    Iwuchukwu OF, Nagar S (2010) Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources. Xenobiotica 40:102–108
    Jeon JS, Oh SJ, Lee JY, Ryu CS, Kim YM, Lee BH, Kim SK (2015) Metabolic characterization of meso-dihydroguaiaretic acid in liver microsomes and in mice. Food Chem Toxicol 76:94–102
    Jing WH, Song YL, Yan R, Wang YT (2013) Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry. J Pharm Biomed Anal 77:175–188
    Kamel A, Harriman S (2013) Inhibition of cytochrome P450 enzymes and biochemical aspects of mechanism-based inactivation (MBI). Drug Discov Today Technol 10:177–189
    Khojasteh SC, Prabhu S, Kenny JR, Halladay JS, Lu AY (2011) Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 36:1–16
    Kim SJ, You J, Choi HG, Kim JA, Jee JG, Lee S (2015) Selective inhibitory effects of machilin A isolated from Machilus thunbergii on human cytochrome P450 1A and 2B6. Phytomedicine 22:615–620
    Komura H, Iwaki M (2012) In vitro liver systems to study induction/inhibition: prediction of in vivo metabolism and drug–drug interactions. In: Lyubimov AV (ed) Encyclopedia of drug metabolism and interactions, 1st edn. Wiley, New York
    Kosjek T, Zigon D, Kralj B, Heath E (2008) The use of quadrupole-time-of-flight mass spectrometer for the elucidation of diclofenac biotransformation products in wastewater. J Chromatogr A 1215:57–63
    Kumar SV, Saravanan D, Kumar B, Jayakumar A (2014) An update on prodrugs from natural products. Asian Pacific J Trop Med 7:S54–S59
    Kurogi K, Chepak A, Hanrahan MT, Liu MY, Sakakibara Y, Suiko M, Liu MC (2014) Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis. Eur J Pharm Sci 62:40–48
    Lee M, Park J, Lim M, Seong SJ, Lee J, Seo JJ, Park Y, Lee HW, Yoon Y (2012) High-throughput screening of inhibitory effects of Bo-yang-hwan-o-tang on human cytochrome P450 isoforms in vitro using UPLC/MS/MS. Anal Sci 28:1197–1201
    Li Y, Ren G, Wang YX, Kong WJ, Yang P, Wang YM, Li YH, Yi H, Li ZR, Song DQ, Jiang JD (2011) Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J Transl Med 9:62
    Li X, Wang K, Wei W, Liu YY, Gong L (2013) In vitro metabolism of brucine by human liver microsomes and its interactions with CYP substrates. Chem Biol Interact 204:140–143
    Li X, Hu J, Wang B, Sheng L, Liu Z, Yang S, Li Y (2014) Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb–drug interactions mediated via P-gp. Toxicol Appl Pharmacol 275:163–175
    Liang Y, Zhou Y, Zhang J, Liu Y, Guan T, Wang Y, Xing L, Rao T, Zhou L, Hao K, Xie L, Wang GJ (2013) In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein. Phytomedicine 20:1030–1038
    Liu C, Cao Y-F, Fang Z-Z, Zhang Y-Y, Hu C-M, Sun X-Y, Huang T, Zeng J, Fan X-R, Hong M (2012) Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction. Fitoterapia 83:1415–1419
    Lu C, Li P, Gallegos R, Uttamsingh V, Xia CQ, Miwa GT, Balani SK, Gan LS (2006) Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes. Drug Metab Dispos 34:1600–1605
    Lubin A, Deirdre C, Augustijns P, Cuyckens F (2015) One drop chemical derivatization—DESI–MS analysis for metabolite structure identification. J Mass Spectrom 50:871–878
    Ma JY, Zhou X, Fu J, Hu T, Or PM, Feng R, He CY, Chen WJ, Zhang X, Chen Y, Wang Y, Yeung JH (2014a) Metabolite profiling analysis of FR429, an ellagitannin purified from Polygonum capitatum, in rat and human liver microsomes, cytosol and rat primary hepatocytes in vitro. Chem Biol Interact 220:33–40
    Ma HY, Sun DX, Cao YF, Ai CZ, Qu YQ, Hu CM, Jiang C, Dong PP, Sun XY, Hong M, Tanaka N, Gonzalez FJ, Ma XC, Fang ZZ (2014b) Herb–drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7. Toxicol Appl Pharmacol 277:86–94
    Ma GY, Cao YF, Hu CM, Fang ZZ, Sun XY, Hong M, Zhu ZT (2014c) Comparison of inhibition capability of scutellarein and scutellarin towards important liver UDP-glucuronosyltransferase (UGT) isoforms. Phytother Res 28:282–286
    Ma L, Zhao L, Hu H, Qin Y, Bian Y, Jiang H, Zhou H, Yu L, Zeng S (2014d) Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug–drug interaction in rats. J Ethnopharmacol 153:864–871
    Ma Y, Xie W, Tian T, Jin Y, Xu H, Zhang K, Du Y (2016a) Identification and comparative oridonin metabolism in different species liver microsomes by using UPLC-Triple-TOF–MS/MS and PCA. Anal Biochem 511:61–73
    Ma Z, Shi X, Zhang G, Guo F, Shan L, Cai J (2016b) Metabolism and metabolic inhibition of xanthotoxol in human liver microsomes. Evid Based Complement Alternat Med 2016:1–8
    Marcsisin SR, Jin X, Bettger T, McCulley N, Sousa JC, Shanks GD, Tekwani BL, Sahu R, Reichard GA, Sciotti RJ, Melendez V, Pybus BS (2013) CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC–MS analysis: a possible metabolic link to blackwater fever. Malar J 12:214
    Marques LMM, Silva-Junior EA, Gouvea DR, Vessecchi R, Pupo MT, Lopes NP, Kato MJ, Oliveira ARM (2014) In vitro metabolism of the alkaloid piplartine by rat liver microsomes. J Pharm Biomed Anal 95:113–120
    Martignoni M, Groothuis GMM, Kanter R (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–894
    Mazzari AL, Prieto JM (2014) Herbal medicines in Brazil: pharmacokinetic profile and potential herb–drug interactions. Front Pharmacol 5:162
    Mehbub MF, Perkins MV, Zhang W, Franco CMM (2016) New marine natural products from sponges (Porifera) of the order Dictyoceratida (2001 to 2012); a promising source for drug discovery, exploration and future prospects. Biotechnol Adv 34:473–491
    Misaka S, Kawabe K, Onoue S, Werba JP, Giroli M, Tamaki S, Kan T, Kimura J, Watanabe H, Yamada S (2013) Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinet 28:244–249
    Modarai M, Silva E, Suter A, Heinrich M, Kortenkamp A (2009) Safety of herbal medicinal products: echinacea and selected alkylamides do not induce CYP3A4 mRNA expression. Evid Based Complement Alternat Med 2011:1–7
    Mohutsky M, Hall SD (2014) Irreversible enzyme inhibition kinetics and drug–drug interactions. In: Nagar S, Argikar U, Tweedie D (eds) Enzyme kinetics in drug metabolism, 1st edn. Springer, New York
    Moore TW, Zhu S, Randolph R, Shoji M, Snyder JP (2014) Liver S9 fraction-derived metabolites of curcumin analogue UBS109. ACS Med Chem Lett 5:288–292
    Moreira FL, de Souza GH, Rodrigues IV, Lopes NP, de Oliveira AR (2013) A non-michaelian behavior of the in vitro metabolism of the pentacyclic triterpene alfa and beta amyrins by employing rat liver microsomes. J Pharm Biomed Anal 84:14–19
    Moreira FL, Habenschus MD, Barth T, Marques LMM, Pilon AC, Bolzani VS, Vessecchi R, Lopes NP, de Oliveira ARM (2016) Metabolic profile and safety of piperlongumine. Sci Reports. doi: 10.1038/srep33646
    Nettleton DO, Einolf HJ (2011) Assessment of cytochrome P450 enzyme inhibition and inactivation in drug discovery and development. Curr Top Med Chem 11:382–403
    Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335
    Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629–661
    Nilsson A, Goodwin RJ, Shariatgorji M, Vallianatou T, Webborn PJ, Andren PE (2015) Mass spectrometry imaging in drug development. Anal Chem 87:1437–1455
    Ning J, Yu ZL, Hu LH, Wang C, Huo XK, Deng S, Hou J, Wu JJ, Ge GB, Ma XC, Yang L (2015) Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity. Drug Metab Dispos 43:299–308
    Njuguna NM, Masimirembwa C, Chibale K (2012) Identification and characterization of reactive metabolites in natural products-driven drug discovery. J Nat Prod 75:507–513
    Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, Macintyre F, Rance DJ, Wastall P (1997) The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharm Exp Therap 283:46–58
    Pan Y, Tiong KH, Abd-Rashid BA, Ismail Z, Ismail R, Mak JW, Ong CE (2014) In vitro effect of important herbal active constituents on human cytochrome P450 1A2 (CYP1A2) activity. Phytomedicine 21:1645–1650
    Petronilho S, Maraschin M, Coimbra MA, Rocha SM (2012) In vitro and in vivo studies of natural products: a challenge for their valuation. The case study of chamomile (Matricariarecutita L.). Ind Crop Prod 40:1–12
    Plant N (2004) Strategies for using in vitro screens in drug metabolism. Drug Discov Today 9:328–336
    Pondugula SR, Flannery PC, Abbott KL, Coleman ES, Mani S, Samuel T, Xie W (2015) Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. Toxicol Lett 232:580–589
    Pouyfung P, Prasopthum A, Sarapusit S, Srisook E, Rongnoparut P (2014) Mechanism-based inactivation of cytochrome P450 2A6 and 2A13 by Rhinacanthus nasutus constituents. Drug Metab Pharmacokinet 29:75–82
    Pu QH, Shi L, Yu C (2015) Time-dependent inhibition of CYP3A4 by gallic acid in human liver microsomes and recombinant systems. Xenobiotica 45:213–217
    Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, Tu CX (2013) Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol 56:392–397
    Rendic SP, Guengerich FP (2015) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem Res Toxicol 28:38–42
    Roe AL, Paine MF, Gurley BJ, Brouwer KR, Jordan S, Griffiths JC (2016) Assessing natural product–drug interactions: an end-to-end safety framework. Regul Toxicol Pharmacol 76:1–6
    Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N (2015) Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification. Drug Metab Dispos 43:1823–1837
    Salminen KA, Meyer A, Jerabkova L, Korhonen LE, Rahnasto M, Juvonen RO, Imming P, Raunio H (2011) Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids. Phytomedicine 18:533–538
    Schneider KJ, DeCaprio AP (2013) Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation. Chem Res Toxicol 26:1755–1764
    Seibert E, Tracy TS (2014) Fundamentals of enzyme kinetics. In: Nagar S, Argikar U, Tweedie D (eds) Enzyme kinetics in drug metabolism, 1st edn. Springer, New York
    Shen Q, Zuo M, Ma L, Tian Y, Wang L, Jiang H, Zhou Q, Zhou H, Yu L, Zeng S (2014) Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity. Chem Biol Interact 224:89–99
    Shimada T (2006) Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21:257–276
    Sinz MA (2012) In vitro and in vivo models of drug metabolism. In: Lyubimov AV (ed) Encyclopedia of drug metabolism and interactions, 1st edn. Wiley, New York
    Soler C, Hamilton B, Furey A, James KJ, Mañes J, Picó Y (2006) Comparison of four mass analyzers for determining carbosulfan and its metabolites in citrus by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20:2151–2164
    Song J-H, Sun D-X, Chen B, Ji D-H, Pu J, Xu J, Tian F-D, Guo L (2011) Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug–drug interactions. J Biosci 36:879–885
    Song M, Hong M, Lee MY, Jee JG, Lee YM, Bae JS, Jeong TC, Lee S (2013) Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. Food Chem Toxicol 59:549–553
    Song YL, Jing WH, Yan R, Wang YT (2014) Metabolic characterization of (±)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry. J Pharm Biomed Anal 90:98–110
    Song JH, Cui L, An LB, Li WT, Fang ZZ, Zhang YY, Dong PP, Wu X, Wang LX, Gonzalez FJ, Sun XY, Zhao DW (2015) Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis. Phytother Res 29:1658–1664
    Spaggiari D, Geiser L, Rudaz S (2014) Coupling ultra-high-pressure liquid chromatography with mass spectrometry for in vitro drug-metabolism studies. Trends Anal Chem 63:129–139
    Stalder R, Roth GP (2013) Preparative microfluidic electrosynthesis of drug metabolites. ACS Med Chem Lett 4:1119–1123
    Su S, Cheng X, Wink M (2015) Natural lignans from Arctium lappa modulate P-glycoprotein efflux function in multidrug resistant cancer cells. Phytomedicine 22:301–307
    Subramarian M, Tracy T (2012) Methods for determination of enzyme kinetics and metabolic rates. In: Lyubimov AV (ed) Encyclopedia of drug metabolism and interactions, 1st edn. Wiley, New York
    Sullivan GJ, Hay DC, Park IH, Fletcher J, Hannoun Z, Payne CM, Dalgetty D, Black JR, Ross JA, Samuel K, Wang G, Daley GQ, Lee JH, Church GM, Forbes SJ, Iredale JP, Wilmut I (2010) Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 51:329–335
    Szakacs G, Varadi A, Ozvegy-Laczka C, Sarkadi B (2008) The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 13:379–393
    Tao X, Zheng L, Qi Y, Xu Y, Xu L, Yin L, Han X, Liu K, Peng J (2014) Inhibitory effects of dioscin on cytochrome P450 enzymes. RSC Adv 4:54026–54031
    Testa B, Pedretti A, Vistoli G (2012) Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discov Today 17:549–560
    Thelingwani RS, Dhansay K, Smith P, Chibale K, Masimirembwa CM (2012) Potent inhibition of CYP1A2 by Frutinone A, an active ingredient of the broad spectrum antimicrobial herbal extract from P. fruticosa. Xenobiotica 42:989–1000
    Ueng Y-F, Chen C-C, Yamazaki H, Kiyotani K, Chang Y-P, Lo W-S, Li D-T, Tsai P-L (2013) Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarin chalepensin. Drug Metab Pharmacokinet 28:229–238
    Vacek J, Papouskova B, Kosina P, Vrba J, Kren V, Ulrichova J (2012) Biotransformation of flavonols and taxifolin in hepatocyte in vitro systems as determined by liquid chromatography with various stationary phases and electrospray ionization-quadrupole time-of-flight mass spectrometry. J Chromatogr B 899:109–115
    Vacek J, Papouskova B, Vrba J, Zatloukalova M, Kren V, Ulrichova J (2013) LC–MS metabolic study on quercetin and taxifolin galloyl esters using human hepatocytes as toxicity and biotransformation in vitro cell model. J Pharm Biomed Anal 86:135–142
    Van LM, Sarda S, Hargreaves JA, Rostami-Hodjegan A (2009) Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism. J Pharm Sci 98:763–771
    Vrba J, Havlikova M, Gerhardova D, Ulrichova J (2014) Palmatine activates AhR and upregulates CYP1A activity in HepG2 cells but not in human hepatocytes. Toxicol In Vitro 28:693–699
    Vrba J, Papouskova B, Pyszkova M, Zatloukalova M, Lemr K, Ulrichova J, Vacek J (2015) Metabolism of palmatine by human hepatocytes and recombinant cytochromes P450. J Pharm Biomed Anal 102:193–198
    Wang L, Sweet DH (2013) Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb salvia miltiorrhiza (Danshen). Drug Metab Pharmacokinet 28:220–228
    Wang H, Wang K, Mao X, Zhang Q, Yao T, Peng Y, Zheng J (2015) Mechanism-based inactivation of CYP2C9 by linderane. Xenobiotica 45:1–10
    Wienkers LC, Rock B (2014) Multienzyme kinetics abd sequential metabolism. In: Nagar S, Argikar AA, Tweedie D (eds) Enzyme kinetics in drug metabolism, 1st edn. Springer, New York
    Wilk-Zasadna I, Bernasconi C, Pelkonen O, Coecke S (2015) Biotransformation in vitro: an essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data. Toxicology 332:8–19
    Wolfender JL, Marti G, Thomas A, Bertrand S (2015) Current approaches and challenges for the metabolite profiling of complex natural extracts. J Chromatogr A 1382:136–164
    Wu L-X, Guo C-X, Qu Q, Yu J, Chen W-Q, Wang G, Fan L, Li Q, Zhang W, Zhou H-H (2012) Effects of natural products on the function of human organic anion transporting polypeptide 1B1. Xenobiotica 42:339–348
    Wu H, Guo J, Chen S, Liu X, Zhou Y, Zhang X, Xu X (2013) Recent developments in qualitative and quantitative analysis of phytochemical constituents and their metabolites using liquid chromatography-mass spectrometry. J Pharm Biomed Anal 72:267–291
    Wu W, Hu N, Zhang Q, Li Y, Li P, Yan R, Wang Y (2014) In vitro glucuronidation of five rhubarb anthraquinones by intestinal and liver microsomes from humans and rats. Chem Biol Interact 219:18–27
    Xiao J, Högger P (2013) Metabolism of dietary flavonoids in liver microsomes. Cur Drug Metab 14:381–391
    Xie Q, Chen Y, Liu F, Zhong Z, Zhao K, Ling Z, Wang F, Tang X, Wang Z, Liu L, Liu X (2016) Interspecies differences in metabolism of deoxypodophyllotoxin in hepatic microsomes from human, monkey, rat, mouse and dog. Drug Metab Pharmacokinet 31:314–322
    Xing J, Kirby BJ, Whittington D, Wan Y, Goodlett DR (2012) Evaluation of P450 inhibition and induction by artemisinin antimalarials in human liver microsomes and primary human hepatocytes. Drug Metab Dispos 40:1757–1764
    Yang QC, Wu WH, Han FM, Chen Y (2009) Identification of in vivo and in vitro metabolites of palmatine by liquid chromatography-tandem mass spectrometry. J Pharm Pharmacol 61:647–652
    Yu HE, Oh SJ, Ryu JK, Kang JS, Hong JT, Jung JK, Han SB, Seo SY, Kim YH, Park SK, Kim HM, Lee K (2014) Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats. Phytother Res 28:568–578
    Yuan C, Chen D, Wang S (2015) Drug confirmation by mass spectrometry: identification criteria and complicating factors. Clin Chim Acta 438:119–125
    Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Therap 138:103–141
    Zhang D, Luo G, Ding X, Lu C (2012a) Preclinical experimental models of drug metabolism and disposition in drug discovery and development. Acta Pharm Sin B 2:549–561
    Zhang YS, Tu YY, Gao XC, Yuan J, Li G, Wang L, Deng JP, Wang Q, Ma RM (2012b) Strong inhibition of celastrol towards UDP-glucuronosyl transferase (UGT) 1A6 and 2B7 indicating potential risk of UGT-based herb–drug interaction. Molecules 17:6832–6839
    Zhao L, Zang B, Qi W, Chen F, Wang H, Kano Y, Yuan D (2016) Pharmacokinetic study of isocorynoxeine metabolites mediated by cytochrome P450 enzymes in rat and human liver microsomes. Fitoterapia 111:49–57
    Zheng J, Yujie T, Sun M, Zhao Y, Li Q, Zhou J, Wang Y (2013) Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice. Pharmazie 68:41–46
    Zhou H, Jiang H, Yao T, Zeng S (2007) Fragmentation study on the phenolic alkaloid neferine and its analogues with anti-HIV activities by electrospray ionization tandem mass spectrometry with hydrogen/deuterium exchange and its application for rapid identification of in vitro microsomal metabolites of neferine. Rap Comm Mass Spectr 21:2120–2128
    Zhu QN, Zhang D, Jin T, Wu Q, Liu J, Lu YF (2013) Rutaecarpine effects on expression of hepatic phase-1, phase-2 metabolism and transporter genes as a basis of herb–drug interactions. J Ethnopharmacol 147:215–219
    Zhu W, Hu Q, Hanke N, van Koppen CJ, Hartmann RW (2014) Potent 11beta-hydroxylase inhibitors with inverse metabolic stability in human plasma and hepatic S9 fractions to promote wound healing. J Med Chem 57:7811–7817
    Zientek MA, Youdim K (2015) Reaction phenotyping: advances in the experimental strategies used to characterize the contribution of drug-metabolizing enzymes. Drug Metab Dispos 43:163–181